Chronic Diabetic Wounds The team, which includes a dermatologist, initially developed a potential treatment using mesenchymal stem cells and an FDA-approved scaffold to help regenerate dermal tissue and restart the healing process. They are now refining the therapeutic techniques and creating a Master Cell Bank of pure and effective stem cells, establishing standard operating procedures for use in diabetic wound repair and hope to launch human clinical trials within three years. This team is supported by a CIRM translational grant and philanthropy.